“The Evaluation of Paclitaxel Effects on the Caco-2 Cell Line of Colon Cancer Patients”. 2022. Journal of Pharmaceutical Negative Results, September, 459-63. https://doi.org/10.47750/pnr.2022.13.S01.56.